Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I doubt if all those trades are anything to do with him retiring,but if they are,an holdings rns is mantory on anything bought or sold over 3% of the shares in issue.
just looked at the rns's,seems a load of institutional investors have bought or increased their holdings since February,which shows up in a rise on the 3month chart,not in here but couldn't help noticing the trades going through on the cnbc ticker(a sky/virgin business channel). noticed the 4mill shares held in treasury for management bonuses or similar payments,nice if you can get it.lol..atb.
There was an rns about Paul Adams stepping down at 7am but all the selling came quite a while after.... Il keep my eye this tomorrow
blimey,I see what you mean,30% of the shares in issue traded or swapped?who knows.
Anyone have any idea why there were so many huge sells this afternoon? Way over the usual volume
Hi Dan, I suppose it is my preference not to draw attention to this post. I will say that the news of additional shares is (or might be) a little ambiguous. The tranche that is being issued upon conversion of convertible debt is probably regarded as a good thing. Debt must (as you surely know) be paid back, but newly issued shares do not have to be paid back. The second tranche may very well be a capital raise. The news release was unclear to me; but one thing about which you and I are in accord is that a token discount from the EBQ closing price shows that investors are getting involved because they believe in the company rather than because they think they can reap quick profits from flipping the new shares. I think I mentioned ABDP to you a few days ago on one bb, maybe this one. On 13.02.2014, there was news of an Approval by the local government (at Wiltshire, I think) so as to allow ABDP to construct a new plant. I think that the shares rose from 150p to 158p. An underfollowed company in a good sector (IMO). Also, some people like the 12.02.2014 news at ODX. Rob229
I'm ever so sorry I haven't replied to you STILL! I just popped back on here having seen today's RNS where an extra 22.8% shares have been issued. Not great in terms of MC but at least they weren't sold at much of a discount - it suggests you really might be on to something here! Speak to you soon and good luck, Dan
Good evening Dan, A remarkable coincidence. EBQ has been a v quiet board; today there is another poster. EBQ shares had not traded for days; today, there is v high volume. Maybe you would like to think about EBQ. I am intrigued that Herald Investment Trust holds a position. If I understand the business of EBQ, I think it is an important type of business. To me, it seems like a mini Gartner Group, which you may or may not know. I am not 100% sure what EBQ does, but it impresses me. I tried to buy @ 118.50p last week, but the market maker would not let me in. Anyway, if people become unhappy about off-topic posts between you and me here, please consider CAM, which owns tea estates. The company name: Camellia plc. When in the evenings I have a cup of tea, I think I am contributing to CAM. I own a total of 35 CAM shares, but I am happy about them. There are fewer than 3 million outstanding shares, and the float is a significantly smaller number. As for AMED, I have to think a little more about what to do. I think that the percentage ownership in the Chinese shipbuilding firm is a disclosed percentage. I do not have the figure handy. Re my AMED position, I am -- perhaps like you -- bashful about discussing amounts. I own small stakes in numerous companies quoted in London, Toronto and NY. [Oddly, I have, in large measure, migrated away from NY. I feel as though, in comparison to me, many investors possess vast knowledge advantages. I prefer less crowded markets. I am sure you have seen on AIM good companies that trade only 3 times a day. In NY, the volume is so high that it is easy for one to feel overwhelmed.] Unless a share is low-beta and pays a dividend, I limit initial purchases to the range of 2500 to 3000 USD. In the case of AMED, I adhered to this rule. The unexpected rise to 3p occurred while I was sound asleep. Had I seen that rise, maybe I would have sold. With regard to AMED at the close today, I should try to evaluate the news. Is it a glimpse of a promising future? Or is it a spike on an insubstantial basis? Very hard to be objective, but I think the news MAY BE a glimpse of a promising future. I was drawn to AMED in part by its investment in the broker of commodity metals. I think the name of this investee is MGR or something like that. The interim report for AMED seemed to say that the small investment was already yielding a profit. Please be assured I am a humble person. I have made many mistakes in the market. I never boast, I never gloat. I am happy to have had some good experiences in the market. If AMED works out for me, it will be nice to include it on my mental list of good trades. Time will tell. A paper profit means v little, as you know. I would welcome your counsel. Happy for you re the rise in MOS. What else is on your radar this evening? ABDP, which seems like a high-grade, closely held company, may have bottomed. Regards, Rob229
Good day Sir, AMED has had a v interesting day. Although I reckon I could have been caught on a spike had a bought in this morning because it opened 290 % up so anyone buying then would be in a huge loss right now. How much have you made on AMED? Are you going to sell or hold out for more? If I were you I'd hold out off more. I reckon there was inevitably lots of selling after an incredible rise this morning, before rising further in the coming days and weeks because that RNS was incredible! USD 1,700,000,000 is a HUGE figure and the market cap is tiny in comparison! (although of course we don't know the split or what those conditions precedent are) Good shout from the looks of it. Well done!
of the shares in issue traded today,70% of those in just two large trades?
Does anyone know why this share is plateauing rather than dropping, having topped. Is there a reconstruction emerging I see a number of option-related RNSs.
Business data consultancy Ebiquity has bought advertising auditing firm FirmDecisions in a deal that could be worth up to seven million pounds. FirmDecisions is being acquired for an upfront cost of £1m which is being paid from Ebiquity's existing banking facilities. That figure could rise to £7m, depending on the performance of the FirmDecisions business in the three financial years ending April 30th, 2014. FirmDecisions works in media and production cost auditing, specialising in the advertiser supply chain. The company helps its advertiser clients benefit from contractual compliance by their agencies. The company is being acquired from its current and previous managers, including Stephen Broderick, one of the founders, who will remain as Chief Executive. FirmDecisions' unaudited revenue for the year ended June 30th was approximately £2m and it generated an operating profit before highlighted items of approximately £0.3m. The company employs approximately 20 people.
Michael Greenlees, Chief Executive Officer of Ebiquity: "FirmDecisions is the first name in media financial compliance with experience across a wide range of global clients. This acquisition enables Ebiquity to bring increased transparency to the media transaction market-place and a higher level of advertiser confidence in contractual compliance."
Acquisition of FirmDecisions Ebiquity plc is pleased to announce the acquisition of the entire issued share capital of FirmDecisions ASJP Group Limited, the holding company of the FirmDecisions group ("FirmDecisions" or the "Acquisition"). FirmDecisions is being acquired for an initial consideration of £1m which is being satisfied from existing banking facilities. The maximum total consideration is up to £7m, payable in cash, depending on the performance of the FirmDecisions business in the three financial years ending 30 April 2014. The Acquisition will be earnings enhancing in the first full financial year. FirmDecisions specialises in media and production cost auditing, with specific reference to the advertiser supply chain. FirmDecisions ensures that its advertiser clients benefit from contractual compliance by their agencies and transparency of transactional value. FirmDecisions is being acquired from its current and previous managers, including Stephen Broderick, one of FirmDecisions' founders, who will remain as Chief Executive of the FirmDecisions business. FirmDecisions' unaudited revenue for the year ended 30 June 2012 was approximately £2m and it generated an operating profit before highlighted items of approximately £0.3m. FirmDecisions employs approximately 20 people.
http://www.investegate.co.uk/Article.aspx?id=201208030700102177J
Underlying diluted earnings per share were 7.40p (2011: 6.02p), an increase of 23% over the prior year, reflecting the positive impact of the acquisitions and the use of brought forward tax losses. Net debt increased from £4.5m to £12.2m.
Ebiquity, the media and marketing performance measurement business, has pleased its investors by returning to the black. Pre-tax profit for the year ended April 30th came in at £2.64m (2011: £1.78m loss) on revenues of £52.92m that were up 20% on the previous year's £44.17m, boosted by acquisitions in the Analytics business. Platform revenue fell by 5.0%, largely due to the disposal of Newslive, but retention of clients has again been strong and as a result the renewal rate for advertising monitoring has been maintained at 92% in the year. With the Analytics division growing at 9.0%, offset by a marginal decline in the Platform division, total organic revenue grew by 1.0%. The underlying operating profit margin improved from 12% to 16%, primarily because of the impact of the Xtreme acquisition synergies over a full year this time round.
Ebiquity, the media and marketing performance measurement business, has pleased its investors by returning to the black. Pre-tax profit for the year ended April 30th came in at £2.64m (2011: £1.78m loss) on revenues of £52.92m that were up 20% on the previous year's £44.17m, boosted by acquisitions in the Analytics business. Platform revenue fell by 5.0%, largely due to the disposal of Newslive, but retention of clients has again been strong and as a result the renewal rate for advertising monitoring has been maintained at 92% in the year. With the Analytics division growing at 9.0%, offset by a marginal decline in the Platform division, total organic revenue grew by 1.0%. The underlying operating profit margin improved from 12% to 16%, primarily because of the impact of the Xtreme acquisition synergies over a full year this time round.
Valuation: Rating significantly below proxy comparators We suggest that EPS growth in the region of 15% per year is achievable over the medium term, now that the group has the opportunity to scale its business in overseas markets following the series of acquisitions in FY11 and FY12. Ebiquity is trading significantly below the ratings (see Exhibit 1) accorded to our proxy comparators, whose EPS are growing at a lesser pace
http://www.edisoninvestmentresearch.co.uk/researchreports/EBQ180712update.pdf
Ebiquity takes control of media practice partner By Benjamin Chiou Date: Friday 10 Jun 2011 LONDON (ShareCast) - Media and marketing insights firm Ebiquity has purchased a majority stake in its Russian media practice partner, The Joined Up Media Company (JUMC), for a maximum consideration of £1.2m. "Russia is an increasingly important market to Ebiquity's existing clients and this reinforced capability will allow further cross-selling opportunities," the firm said. Ebiquity has acquired a 50.1% stake in JUMC for an initial consideration of £356,000, with the residual amount being settled over a three-year period, dependent on "certain criteria". "To acquire a majority stake in a company that is recognised locally as the market leader is a real bonus for Ebiquity and is in line with our strategy to deliver a truly global suite of services and products," said chief executive officer Michael Greenlees.
http://www.investegate.co.uk/Article.aspx?id=201106100700092025I
In a move to further establish its global leadership in marketing analytics and insight, Ebiquity (EBQ) has acquired Echo Research, the global reputation analysis, media measurement and stakeholder research specialist, for a maximum consideration of 10 million pounds. Separately, the group revealed that it will be "comfortably in line with market expectations" for the full-year ended 30th April 2011. Ebiquity shares rose 1.5p to 93.5p.